URTICARIA CHRONIC

Clinical trials for URTICARIA CHRONIC explained in plain language.

Never miss a new study

Get alerted when new URTICARIA CHRONIC trials appear

Sign up with your email to follow new studies for URTICARIA CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New hope for chronic hives: Long-Term drug safety trial underway

Disease control Ongoing

This study looks at the long-term safety of a drug called briquilimab for people with chronic hives (urticaria). It includes 67 adults who already took part in a previous briquilimab study. Researchers will track side effects and how well the drug controls hives over time.

Matched conditions: URTICARIA CHRONIC

Phase: PHASE2 • Sponsor: Jasper Therapeutics, Inc. • Aim: Disease control

Last updated Apr 26, 2026 19:36 UTC

URTICARIA CHRONIC

Get alerted when new URTICARIA CHRONIC trials appear

New hope for chronic hives: Long-Term drug safety trial underway